Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,423.88 +155.39 (+0.24%) CMC Crypto 200
1,352.92 -7.40 (-0.54%)
AGIO Jun 2024 20.000 call
| Previous close | 4.2900 |
| Open | N/A |
| Bid | 4.2000 |
| Ask | 4.8000 |
| Strike | 20.00 |
| Expiry date | 2024-06-21 |
| Day's range | 4.2900 - 4.2900 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Simply Wall St.Swelling losses haven't held back gains for Agios Pharmaceuticals (NASDAQ:AGIO) shareholders since they're up 71% over 1 year
Passive investing in index funds can generate returns that roughly match the overall market. But one can do better than...
GlobeNewswireAgios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha- and Beta-Thalassemia – – Additional ENERGIZE Poster Presentation Highlights Improvements in Fatigue and Exercise Capacity in Patients Treated with Mitapivat Compared to Placebo – – Agios to Webcast Virtual Investor Event on June 16, 2024 at 10 a.m. Eastern Time or 4 p.m. Central European Summer Time – CAMBRIDGE, Mass., June 15, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasd
ZacksPrestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?
Prestige Consumer Healthcare (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
